Molecular characterization of the mouse Fas ligand promoter in airway epithelial cells

Biochimica et Biophysica Acta - Gene Structure and Expression

Volumn 1490, Issue 3, 2000, Pages 291-301

  Zhang, Jie ^a   Miranda, Kathleen ^a   Ma, Bei Yang ^a   Fine, Alan ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Airway; Enhancer; FasL; Mouse; Promoter; Transcription

Indexed keywords

FAS ANTIGEN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; LUNG ALVEOLUS EPITHELIUM; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN FAMILY; SEQUENCE ANALYSIS; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION REGULATION;

ANIMALS; BASE SEQUENCE; CELL LINE; CLONING, MOLECULAR; DNA, COMPLEMENTARY; EPITHELIAL CELLS; FAS LIGAND PROTEIN; GENE EXPRESSION; MALE; MEMBRANE GLYCOPROTEINS; MICE; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PROMOTER REGIONS (GENETICS); RESPIRATORY MUCOSA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SEQUENCE ALIGNMENT; SERTOLI CELLS; TRANSCRIPTION, GENETIC; TRANSFECTION;

ANIMALIA; MAMMALIA; RODENTIA;

EID: 0033953389     PISSN: 01674781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4781(99)00212-2     Document Type: Article

References (35)

1. Nagata S., Golstein P. The Fas death factor (review). Science. 267:1995;1449-1456.
2. Watanabe-Fukunaga R., Brannan C.I., Itoh N., Yonehara S., Copeland N.G., Nagata S. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J. Immunol. 148:1992;1274-1279.
3. Ogasawara J., Watanabe-Fukunaga R., Adachi M., Matsuzawa A., Kasugai T., Itoh N., Suda T., Nagata S. Lethal effect of the anti-Fas antibody in mice (published erratum appears in Nature 365 (6446) (1993) 568). Nature. 364:1993;806-809.
4. Sayama K., Yonehara S., Watanabe Y., Miki Y. Expression of Fas antigen on keratinocytes in vivo and induction of apoptosis in cultured keratinocytes. J. Invest. Dermatol. 103:1994;330-334.
5. Ju S.T., Panka D.J., Cui H., Ettinger R., el-Khatib M., Sherr D.H., Stanger B.Z., Marshak-Rothstein A. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation [see comments]. Nature. 373:1995;444-448.
6. Fine A., Anderson N.L., Rothstein T.L., Williams M.C., Gochuico B.R. Fas expression in pulmonary alveolar type II cells. Am. J. Physiol. 273:1997;L64-L71.
7. Suda T., Takahashi T., Golstein P., Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell. 75:1993;1169-1178.
8. Lynch D.H., Watson M.L., Alderson M.R., Baum P.R., Miller R.E., Tough T., Davis-Smith T., Smith C.A., Hunter K., et al. The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity. 1:1994;131-136.
9. Griffith T.S., Brunner T., Fletcher S.M., Green D.R., Ferguson T.A. Fas ligand-induced apoptosis as a mechanism of immune privilege [see comments]. Science. 270:1995;1189-1192.
10. L.E. French, J. Tschopp. Constitutive Fas ligand expression in several non-lymphoid mouse tissues: implications for immune-protection and cell turnover (Review), Beh. Instit. Mitt., 1996, pp. 156-160.
11. Gochuico B.R., Miranda K.M., Hessel E.M., De Bie J.J., Van Oosterhout A.J., Fine A. Airway epithelial Fas ligand expression: potential role in modulating bronchial inflammation. Am. J. Physiol. 274:1998;L444-L449.
12. Crispe I.N. Fatal interactions: Fas-induced apoptosis of mature T cells (Review). Immunity. 1:1994;347-349.
13. O'Connell J., O'Sullivan G.C., Collins J.K., Shanahan F. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J. Exp. Med. 184:1996;1075-1082.
14. Strand S., Hofmann W.J., Hug H., Muller M., Otto G., Strand D., Mariani S.M.S., Krammer P.H., Galle P.R. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells - a mechanism of immune evasion? Nat. Med. 2:1996;1361-1366.
15. Hahne M., Rimoldi D., Schroter et al M. Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape [see comments]. Science. 274:1996;1363-1366.
16. Takahashi T., Tanaka M., Brannan C.I., Jenkins N.A., Copeland N.G., Suda T. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell. 76:1994;969-976.
17. Watanabe-Fukunaga R., Brannan C.I., Copeland N.G., Jenkins N.A., Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature. 356:1992;314-317.
18. Schreiber E., Matthias P., Muller M.M., Schaffner W. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 17:1989;6419.
19. Bohinski R.J., Di Lauro R., Whitsett J.A. The lung-specific surfactant protein B gene promoter is a target for thyroid transcription factor 1 and hepatocyte nuclear factor 3, indicating common factors for organ-specific gene expression along the foregut axis. Mol. Cell. Biol. 14:1994;5671-5681.
20. Jones K.A., Yamamoto K.R., Tjian R. Two distinct transcription factors bind to the HSV thymidine kinase promoter in vitro. Cell. 42:1985;559-572.
21. Jones K.A., Kadonaga J.T., Rosenfeld P.J., Kelly T.J., Tjian R. A cellular DNA-binding protein that activates eukaryotic transcription and DNA replication. Cell. 48:1987;79-89.
22. Graves B.J., Johnson P.F., McKnight S.L. Homologous recognition of a promoter domain common to the MSV LTR and the HSV tk gene. Cell. 44:1986;565-576.
23. Dorn A., Bollekens J., Staub A., Benoist C., Mathis D. A multiplicity of CCAAT box-binding proteins. Cell. 50:1987;863-872.
24. Dorn A., Durand B., Marfing C., Le Meur M., Benoist C., Mathis D. Conserved major histocompatibility complex class II boxes - X and Y - are transcriptional control elements and specifically bind nuclear proteins. Proc. Natl. Acad. Sci. USA. 84:1987;6249-6253.
25. Currie R.A. NF-Y is associated with the histone acetyltransferases GCN5 and P/CAF. J. Biol. Chem. 273:1998;1430-1434.
26. Jump D.B., Badin M.V., Thelen A. The CCAAT box binding factor, NF-Y, is required for thyroid hormone regulation of rat liver S14 gene trascription. J. Biol. Chem. 272:1997;27778-27786.
27. Dooley K.A., Millinder S., Osborne T.F. Sterol regulation of 3-hydroxy-3-methylglutaryl-coenzyme A synthase gene through a direct interaction between sterol regulatory element binding protein and the trimeric CCAAT-binding factor/nuclear factor Y. J. Biol. Chem. 273:1998;1349-1356.
28. Landschulz W.H., Johnson P.F., Adashi E.Y., Graves B.J., McKnight S.L. Isolation of a recombinant copy of the gene encoding C/EBP (published erratum appears in Genes Dev. 8(9) (1994) 1131). Gen. Dev. 2:1988;786-800.
29. Santoro C., Mermod N., Andrews P.C., Tjian R. A family of human CCAAT-box-binding proteins active in transcription and DNA replication: cloning and expression of multiple cDNAs. Nature. 334:1988;218-224.
30. Maity S.N., Golumbek P.T., Karsenty G., de Crombrugghe B. Selective activation of transcription by a novel CCAAT binding factor. Science. 241:1988;582-585.
31. Hooft van Huijsduijnen R., Li X.Y., Black D., Matthes H., Benoist C. Co-evolution from yeast to mouse: cDNA cloning of the two NF-Y (CP-1/CBF) subunits. EMBO J. 9:1990;3119-3127.
32. Sinha S., Maity S.N., Lu J., de Crombrugghe B. Recombinant rat CBF-C, the third subunit of CBF/NFY, allows formation of a protein-DNA complex with CBF-A and CBF-B and with yeast HAP2 and HAP3. Proc. Natl. Acad. Sci. USA. 92:1995;1624-1628.
33. Sinha S., Kim I.S., Sohn K.Y., de Crombrugghe B., Maity S.N. Three classes of mutations in the A subunit of the CCAAT-binding factor CBF delineate functional domains involved in the three-step assembly of the CBF-DNA complex. Mol. Cell. Biol. 16:1996;328-337.
34. Latinis K.M., Norian L.A., Eliason S.L., Koretzky G.A. Two NFAT transcription factor binding sites participate in the regulation of CD95 (Fas) ligand expression in activated human T cells. J. Biol. Chem. 272:1997;31427-31434.
35. Matsui K., Fine A., Zhu B., Marshak-Rothstein A., Ju S.T. Identification of two NF-kappa B sites in mouse CD95 ligand (Fas ligand) promoter: functional analysis in T cell hybridoma. J. Immunol. 161:1998;3469-3473.